Investors

Apitope was set up with initial funding from the Richard Daniels Family and subsequently support from the Wellcome Trust, Sulis Seedcorn Fund (now Wyvern) and the University of Bristol.

In 2008, it raised EUR 10 million from LRM, Vesalius Biocapital, Vinnoff and UHasselt. Additional funding was provided by Fast Forward LLC, an organization founded by the National MS Society, to accelerate promising research discoveries into the development pipeline.